Slideshow

New FDA Warning

Author(s):

James Phelps, MD

A rare but serious reaction to this treatment can have immunological consequences. As with all medications, however, the latest alert does not change how psychiatrists manage the risks.

Related Videos
journey
Related Content
renal
December 20th 2024

Demystifying Lithium Therapy—A Primer for Clinicians: Renal Issues, Part 1

Jonathan M. Meyer, MD, DLFAPA
Blue Light, Depression, and Bipolar Disorder
August 4th 2021

Blue Light, Depression, and Bipolar Disorder

Chris Aiken, MD Kellie Newsome, PMH-NP
bipolar
November 26th 2024

Coping with Diagnostic Uncertainty in Mixed States: Comparing Treatment Risks

James Phelps, MD
Four Myths About Lamotrigine
August 3rd 2021

Four Myths About Lamotrigine

Chris Aiken, MD Kellie Newsome, PMH-NP
bipolar
November 19th 2024

4 Ways to Cope With Bipolar Uncertainty

James Phelps, MD
questions
November 12th 2024

Differential Diagnosis of Mixed States is Nearly Impossible. Here’s How to Cope.

James Phelps, MD
© 2024 MJH Life Sciences

All rights reserved.